Fig. 7From: Preparation and characterization of the myricetin-loaded solid lipid nanoparticles decorated with folic acid-bound chitosan and evaluation of its antitumor and anti-angiogenic activities in vitro and in vivo in mice bearing tumor modelsApoptosis analysis with flow cytometry. Increasing the percentage of SubG1 phase cells indicates the occurrence of apoptosis in MCF-7 cells treated with myricetin-SLN-CS-FA. A control without treatment, B 25 µg/ml, C 35 µg/ml, and D 45 µg/ml of the myricetin-SLN-CS-FABack to article page